We are live on ! Find out more
EVH icon

Evolent Health

218 hedge funds and large institutions have $2.78B invested in Evolent Health in 2022 Q1 according to their latest regulatory filings, with 37 funds opening new positions, 87 increasing their positions, 75 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

54% more first-time investments, than exits

New positions opened: 37 | Existing positions closed: 24

42% more call options, than puts

Call options by funds: $9.86M | Put options by funds: $6.97M

19% more capital invested

Capital invested by funds: $2.34B → $2.78B (+$437M)

16% more repeat investments, than reductions

Existing positions increased: 87 | Existing positions reduced: 75

5% more funds holding

Funds holding: 207218 (+11)

0.53% more ownership

Funds ownership: 94.74%95.26% (+0.53%)

13% less funds holding in top 10

Funds holding in top 10: 87 (-1)

Holders
218
Holders Change
+11
Holders Change %
+5.31%
% of All Funds
3.44%
Holding in Top 10
7
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-12.5%
% of All Funds
0.11%
New
37
Increased
87
Reduced
75
Closed
24
Calls
$9.86M
Puts
$6.97M
Net Calls
+$2.9M
Net Calls Change
-$8.6M
Name Holding Trade Value Shares
Change
Change in
Stake
SAM
26
Silvercrest Asset Management
New York
$28M -$122K -4,656 -0.5%
Norges Bank
27
Norges Bank
Norway
$26.1M -$2.17M -82,761 -9%
Invesco
28
Invesco
Georgia
$21M +$14.7M +560,438 +632%
Principal Financial Group
29
Principal Financial Group
Iowa
$20.2M +$6.48M +247,386 +65%
Charles Schwab
30
Charles Schwab
California
$19M +$397K +15,177 +3%
KCM
31
Kornitzer Capital Management
Kansas
$17.3M
Fuller & Thaler Asset Management
32
Fuller & Thaler Asset Management
California
$16.1M +$13M +497,140 +23,821%
GC
33
Guggenheim Capital
Illinois
$15.5M -$487K -18,615 -4%
SCA
34
Summit Creek Advisors
Minnesota
$14.4M +$569K +21,746 +5%
GF
35
Gabelli Funds
New York
$14.2M -$576K -22,000 -5%
PWAM
36
Park West Asset Management
California
$13.8M -$3.18M -121,283 -22%
PCM
37
Peregrine Capital Management
Minnesota
$13.5M -$1.9M -72,557 -15%
State of Wisconsin Investment Board
38
State of Wisconsin Investment Board
Wisconsin
$13.5M -$275K -10,500 -2%
Bank of America
39
Bank of America
North Carolina
$13.4M -$2.1M -80,094 -16%
SAM
40
Sectoral Asset Management
Quebec, Canada
$12.7M -$4.19M -159,859 -29%
RPA
41
Rock Point Advisors
Vermont
$12.6M +$66.4K +2,535 +0.7%
VCM
42
Voce Capital Management
California
$12.1M +$830K +31,684 +9%
Marshall Wace
43
Marshall Wace
United Kingdom
$11.8M +$3.51M +134,134 +58%
D.E. Shaw & Co
44
D.E. Shaw & Co
New York
$11.2M +$6.01M +229,471 +196%
KCM
45
Kennedy Capital Management
Missouri
$10.9M -$1.03M -39,180 -10%
FG
46
Formula Growth
Quebec, Canada
$9.83M -$696K -26,580 -8%
Two Sigma Investments
47
Two Sigma Investments
New York
$8.95M +$1.54M +58,706 +27%
1M
48
13D Management
New York
$8.71M -$5.48M -209,403 -44%
PA
49
Perceptive Advisors
New York
$8.07M +$6.55M +250,000 New
TLP
50
Tri Locum Partners
New York
$7.48M +$168K +6,402 +3%

EVH Hedge Fund Activity: Q1 2022 in Review

218 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Evolent Health (EVH) for Q1 2022, worth a combined $2.78B — up 19% from $2.34B a quarter earlier.

Buyers outnumbered sellers: 37 funds opened new EVH positions and 24 closed out — a net gain of 13 holders — while 87 added to existing stakes and 75 trimmed.

The largest buyer was Point72 Asset Management, adding an estimated $25.9M. The largest seller was Great Lakes Advisors, exiting entirely with an estimated $21.8M sold.

  • 218 institutional investors held Evolent Health (EVH) as of Q1 2022, up from 207 in Q4 2021.
  • Funds reported $2.78B of Evolent Health stock for Q1 2022, up 19% quarter-over-quarter.
  • 37 funds opened new Evolent Health positions in Q1 2022 and 24 closed out, a net change of +13 holders.
  • The largest Evolent Health buyer in Q1 2022 was Point72 Asset Management, an estimated $25.9M added.
  • The largest Evolent Health seller in Q1 2022 was Great Lakes Advisors, an estimated $21.8M sold.

Based on aggregated 13F filings for Q1 2022.